首页|FGFR1蛋白在ER阳性乳腺癌中的表达情况及其与ER、预后的相关性

FGFR1蛋白在ER阳性乳腺癌中的表达情况及其与ER、预后的相关性

扫码查看
目的 探讨成纤维细胞生长因子受体1(FGFR1)蛋白在雌激素受体(ER)阳性乳腺癌中的表达水平及与ER、预后的关系.方法 回顾性分析89 例ER阳性乳腺癌患者临床资料.所有患者均行手术治疗,术后及时送检肿瘤标本,经免疫组织化学法检测FGFR1 蛋白表达情况.统计FGFR1 蛋白表达在ER阳性乳腺癌中的表达水平,分析不同FGFR1 表达患者临床病理特征差异;比较不同FGFR1 蛋白表达患者生存率差异.结果 89 例ER阳性乳腺癌患者体内均存在FGFR1 蛋白表达,其中高表达58 例,低表达31 例;高、低表达组肿瘤分期、肿瘤大小、淋巴结转移、ER表达相比,差异有统计学意义(P<0.05).随访3 年,89 例ER阳性患者存活71 例,存活率为79.78(71/89);FGFR1 蛋白低表达组存活率为93.55%(29/31),高于FGFR1 蛋白高表达组72.41%(42/58),差异有统计学意义(x2 =5.593,P =0.018).结论 FGFR1 蛋白在ER阳性乳腺癌中存在不同程度表达,且 FGFR1 蛋白高表达患者ER表达水平偏低,并可对患者预后造成影响.
FGFR1 Protein Expression in ER-positive Breast Cancer and Its Correlation with ER and Prognosis
Objective To explore the expression level of fibroblast growth factor receptor 1(FGFR1)protein in oestro-gen receptor(ER)-positive breast cancer and its relationship with ER and prognosis.Methods Clinical data of 89 ER-positive breast cancer patients were also retrospectively analyzed.All patients underwent surgical treatment,and the tumor samples were tested for FGFR1 protein expression by immunohistochemistry,the expression level of FGFR1 protein expression in ER-positive breast cancer was counted,and the clinicopathological characteristics of patients with different FGFR1 expression were analyzed,and the survival rate of patients with different FGFR1 protein expression were compared.Results FGFR1 protein expression was present in all 89 patients with ER-positive breast cancer,Among these,in 58 cases with high expression,Low expression in 31 ca-ses;Compared with tumor stage,tumor size,lymph node metastasis,and ER expression,The difference was statistically significant(P<0.05);Follow-up for 3 years,89 ER-positive patients survived 71,The survival rate was 79.78 5%(71/89);The survival rate of the FGFR1 protein low expression group was 93.55%(29/31),Higher than 72.41%(42/58)of high FGFR1 protein ex-pression group,The difference was statistical significant(x2 =5.593,P = 0.018).Conclusion FGFR1 protein is widely ex-pressed in ER-positive breast cancer,and ER expression has low levels in patients with high FGFR1 protein expression,and can affect the prognosis of patients,which can strengthen the treatment of patients with high FGFR1 protein expression to improve the long-term survival rate.

Breast cancerEstrogen receptorPathologic featuresClinical prognosis

楚阳光、孙胜、邓小强、何岩

展开 >

462000 河南省漯河市中心医院

乳腺癌 雌激素受体 病理特征 临床预后

2024

实用癌症杂志
江西省肿瘤医院 江西省肿瘤研究所

实用癌症杂志

影响因子:1.241
ISSN:1001-5930
年,卷(期):2024.39(2)
  • 12